Chronic pain is one of the most common yet misunderstood medical conditions worldwide. Many patients seek a definitive solution—a single injection, a surgery, or a medication that will permanently remove the pain. However, chronic pain is rarely a one-time event. It represents a sustained biological process involving inflammation, tissue degeneration, and nervous system adaptation. Understanding why chronic pain persists is essential before evaluating whether stem cell therapy has a meaningful role.

What Is Chronic Pain?

Chronic pain is typically defined as pain lasting longer than three months, but its definition is not purely time-based. Biologically, chronic pain reflects a shift from protective signaling to persistent dysregulation. Acute pain alerts the body to injury and resolves as healing occurs. Chronic pain, in contrast, continues even when the initial injury has stabilized or partially healed. In orthopedic conditions such as knee osteoarthritis, degenerative disc disease, or chronic tendon injury, pain persists because the underlying biological environment remains inflamed and structurally compromised.

Chronic pain should therefore be understood not as a symptom alone, but as a complex interaction between damaged tissue, inflammatory mediators, and altered neural signaling pathways.

What Causes Chronic Pain to Persist?

Most chronic musculoskeletal pain begins with mechanical stress or tissue injury. Over time, repeated loading, aging, metabolic inflammation, or unresolved microtrauma prevent complete recovery. Cartilage thins in osteoarthritis. Discs lose hydration and structural integrity. Tendons develop degenerative changes. These structural abnormalities create abnormal biomechanics, and abnormal biomechanics perpetuate inflammation.

Persistent inflammation is a major driver. Cytokines such as interleukin-1 beta and tumor necrosis factor-alpha remain elevated in chronically affected joints. These molecules sensitize local pain receptors and alter the surrounding microenvironment. Instead of a short inflammatory burst followed by repair, the tissue remains in a low-grade inflammatory state. This chronic inflammatory signaling has been extensively described in osteoarthritis and age-related degeneration

In addition to inflammation and degeneration, the nervous system adapts. Repeated pain signaling over months or years lowers the activation threshold of pain pathways, a phenomenon described as central sensitization. Neural circuits in the spinal cord and brain amplify pain signals, meaning that relatively minor structural abnormalities can produce significant discomfort. This neurological component explains why chronic pain cannot simply be “cut out” or turned off.

Why Chronic Pain Is Not a One-Time Problem

Because chronic pain involves biological changes in multiple systems, it rarely responds to a single intervention. Anti-inflammatory medications suppress inflammatory mediators temporarily but do not restore cartilage or disc structure. Steroid injections can reduce inflammation for weeks or months but do not modify long-term tissue biology. Surgery may correct severe mechanical abnormalities, yet it does not directly recalibrate inflammatory or neural sensitization pathways.

Chronic pain represents a dynamic process. Aging, metabolic health, body weight, activity level, and systemic inflammation continue influencing the tissue environment long after an intervention is performed. This is why pain relief may improve temporarily and then gradually return. Without addressing the biological drivers, the underlying process continues.

How Stem Cell Therapy May Play a Role in Chronic Pain

Stem cell therapy is being investigated as a method of biological modulation rather than mechanical repair. In orthopedic and inflammatory conditions, Umbilical Cord–Derived Mesenchymal Stem Cells (UC-MSCs) are studied for their immunomodulatory and regenerative signaling properties.

UC-MSCs do not function as anesthetics, nor do they permanently reside in the body. Most cells remain biologically active for days to weeks. Their primary mechanism is paracrine signaling. Through the release of cytokines, growth factors, and extracellular vesicles, MSCs influence surrounding cells and immune pathways. This signaling may reduce pro-inflammatory cytokines and promote anti-inflammatory mediators, shifting macrophage activity from a pro-inflammatory state toward a reparative state.

In knee osteoarthritis and other degenerative conditions, this immunomodulatory effect may reduce synovial inflammation and improve the joint microenvironment. Clinical studies suggest that in early to moderate osteoarthritis, MSC therapy can produce meaningful improvements in pain and function lasting months to years, particularly when combined with appropriate rehabilitation and weight control. However, in advanced bone-on-bone degeneration, outcomes are typically shorter in duration, and therapy should be considered supportive rather than definitive.

Can Stem Cells Reverse Chronic Pain Completely?

Current scientific evidence does not support the claim that stem cells cure chronic pain. Chronic pain is influenced by mechanical, metabolic, and neurological factors. While MSCs may reduce inflammation and support tissue signaling, they do not reverse advanced structural collapse or permanently eliminate neural sensitization.

Furthermore, because MSCs do not permanently engraft in most musculoskeletal applications, their effects are time-dependent. Over time, natural aging, mechanical stress, and lifestyle factors can re-establish inflammatory conditions. Repeat treatment may be considered in some cases, but decisions must be individualized and grounded in clinical assessment and available evidence.

Safety and Regulatory Considerations in Thailand

Stem cell therapies in Thailand are regulated under the Thai Food and Drug Administration framework. Laboratories producing clinical-grade UC-MSCs must follow Good Manufacturing Practice standards. Certification through institutions ensures quality control in stem cell processing. These regulatory safeguards are essential because cell viability, sterility, and consistency influence safety and biological effect.

Published clinical studies generally describe MSC therapy as having a favorable safety profile when administered appropriately. However, no medical treatment is without risk. Potential complications include infection, temporary swelling, or discomfort at the injection site. Careful patient selection and physician-led evaluation remain critical.

A Long-Term Strategy for Chronic Pain Management

Chronic pain requires a comprehensive strategy. Weight management, strength training, metabolic optimization, sleep regulation, and stress control all influence inflammatory burden. Stem cell therapy may serve as a biological modulator within that strategy, particularly in early to moderate degeneration where viable tissue remains.

Patients who understand that regenerative therapy is not a one-time mechanical fix but part of a broader plan are more likely to have realistic expectations and meaningful outcomes.

About EDNA Wellness

EDNA Wellness is a private Stem Cell Clinic and Regenerative Medicine Center in Bangkok, Thailand, specializing in Umbilical cord–derived Mesenchymal Stem Cells (UC-MSCs) for knee osteoarthritis and joint pain, stroke and other neuro-related conditions, and stem cell IV infusions for longevity and healthy aging. All treatments are doctor-designed and performed in a sterile clinical setting

For more information or to book a consultation:

LINE: @ednawellness

WhatsApp: +66 (0) 64 505 5599

Website: www.ednawellness.com

References

• Central sensitization and why chronic pain persists (Woolf CJ, Pain, 2011)
• MSC mechanism and clinical translation overview (Pittenger MF, 2019)
• Systemic chronic inflammation as a disease driver (Furman D, Nat Med, 2019)
• OA biology and phenotypes (Mobasheri A, 2019 review)
• MSC therapy evidence in knee osteoarthritis 
• Key clinical concept: injected MSCs often act transiently via paracrine effects